- Pfizer Inc.
- General Electric Co.
- Bristol-Myers Squibb Co.
- Merck & Co. Inc.
- Coley Pharmaceutical Group Inc.
- GlaxoSmithKline PLC
- Eli Lilly & Co.
- Mead Johnson Nutrition Co.
- Medco Health Solutions Inc.
- Genentech Inc.
- Novartis AG
- Nestle SA
- Alcon Inc.
- Merck Research Laboratories
- Sandoz International GmbH
- Pfizer acquires Wyeth in $67bn deal
- Pfizer launches hostile bid for Warner-Lambert
- Pfizer acquires Pharmacia in $59bn all stock deal
- BMS, Pfizer work together on Phase III antithrombotic
- Pfizer buys vaccine company PowderMed in all-cash deal
- Pfizer buying Coley for $164mm
- AHP acquires rest of Genetics Institute for about $1.25bn
- Lilly sells manufacturing site to Covance, signs R&D contract
- BMS sells 15% of Mead through IPO that nets $684mm
- Merck to acquire PBM Medco Containment Services
- Roche to gain full ownership of Genentech in $43.7bn deal
- Novartis buys 25% of Alcon; exercises option for 52% more
- Pfizer acquires Rinat Neuroscience
Ask The Analyst
Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.